Patent Law and Generics: How Patents Protect Innovation in Pharmaceuticals
Patent law in pharmaceuticals balances innovation with access: brands get 12-14 years of exclusivity to recoup $2.6B in R&D, then generics slash prices by 90%. The Hatch-Waxman Act makes this work - but loopholes like evergreening and pay-for-delay threaten it.
Read More